BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7660168)

  • 1. Malignancies after liver transplantation: a comparative review.
    Tan-Shalaby J; Tempero M
    Semin Liver Dis; 1995 May; 15(2):156-64. PubMed ID: 7660168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo malignancies after liver transplantation: a major cause of late death.
    Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidence of de novo neoplasms after liver transplantation].
    Berenguer M; Prieto M; Bustamante M; Carrasco D; López-Andújar R; Mir J; Berenguer J
    Med Clin (Barc); 1998 Oct; 111(13):481-4. PubMed ID: 9859063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancy in pediatric transplant recipients.
    Buell JF; Gross TG; Thomas MJ; Neff G; Muthiah C; Alloway R; Ryckman FC; Tiao GM; Woodle ES
    Semin Pediatr Surg; 2006 Aug; 15(3):179-87. PubMed ID: 16818139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphoproliferative disorders after liver transplantation].
    Pageaux GP
    Gastroenterol Clin Biol; 2001 Apr; 25(4):357-66. PubMed ID: 11449124
    [No Abstract]   [Full Text] [Related]  

  • 8. De novo malignancies following liver transplantation: impact and recommendations.
    Herrero JI
    Liver Transpl; 2009 Nov; 15 Suppl 2():S90-4. PubMed ID: 19877025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant neoplasias in renal transplantation recipients].
    Gómez-Roel X; León-Rodríguez E
    Rev Invest Clin; 2005; 57(2):225-9. PubMed ID: 16524062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report.
    Herrero JI; Alegre F; Quiroga J; Pardo F; Iñarrairaegui M; Sangro B; Rotellar F; Montiel C; Prieto J
    Clin Transplant; 2009; 23(4):532-6. PubMed ID: 19681977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphoproliferative disease and cancer in the transplant patient].
    Herreros J; Flórez S; Echevarría JR; Fernández AL; Pardo Mindán FJ
    Rev Esp Cardiol; 1995; 48 Suppl 7():129-34. PubMed ID: 8775827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo tumors after liver transplantation: a single-institution experience.
    Sanchez EQ; Marubashi S; Jung G; Levy MF; Goldstein RM; Molmenti EP; Fasola CG; Gonwa TA; Jennings LW; Brooks BK; Klintmalm GB
    Liver Transpl; 2002 Mar; 8(3):285-91. PubMed ID: 11910575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up.
    Jain A; Patil VP; Fung J
    Liver Transpl; 2008 Oct; 14(10):1406-11. PubMed ID: 18825680
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of lymphoproliferative disease after liver transplantation.
    Marqués E; Jiménez C; Manrique A; Vallejo GH; Clemares M; Ortega P; Moreno E
    Transplant Proc; 2008 Nov; 40(9):2988-9. PubMed ID: 19010169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancies in renal transplantation: an unmet medical need.
    Dantal J; Pohanka E
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i4-10. PubMed ID: 17456618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancy after solid organ transplantation: an overview.
    Zafar SY; Howell DN; Gockerman JP
    Oncologist; 2008 Jul; 13(7):769-78. PubMed ID: 18614590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
    Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
    Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival after post-transplant lymphoproliferative disease in children.
    Nathanson S; Debray D; Delarue A; Deschênes G
    Pediatr Nephrol; 2002 Aug; 17(8):668-72. PubMed ID: 12185479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.